Exacerbations and their Outcomes International (EXACOS International) - EXACOS-Intl

Study identifier:D5980R00042

ClinicalTrials.gov identifier:NCT04928417

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Exacerbations and their Outcomes International (EXACOS International): Understanding burden of severe exacerbations of COPD and association between frequency of severe exacerbations clinical and health-care utilization outcomes in less well-resourced countries

Medical condition

Chronic Obstructive Pulmonary Disease

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1762

Study type

Observational

Age

40 Years - n/a

Date

Study Start Date: 26 Nov 2021
Primary Completion Date: 30 Nov 2022
Study Completion Date: 30 Nov 2022

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Oct 2023 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria